Diabetes and benign prostatic hyperplasia progression in Olmsted County, Minnesota.

[1]  M. Pollak,et al.  Insulin-like Growth Factors and Prostate Cancer , 2001, Cancer and Metastasis Reviews.

[2]  J. Skyler,et al.  Diabetes trends in the USA , 2002, Diabetes/metabolism research and reviews.

[3]  J. Fraumeni,et al.  Insulin‐like growth factors and risk of benign prostatic hyperplasia † , 2002, The Prostate.

[4]  B. Yawn,et al.  Impact of case ascertainment on recent trends in diabetes incidence in Rochester, Minnesota. , 2002, American journal of epidemiology.

[5]  G. V. Venrooij,et al.  Effect of diabetes mellitus on lower urinary tract symptoms and dysfunction in patients with benign prostatic hyperplasia , 2001, Current urology reports.

[6]  S. Chua,et al.  Prostate cancer risk and serum levels of insulin and leptin: a population-based study. , 2001, Journal of the National Cancer Institute.

[7]  T. Fears,et al.  Insulin-like growth factors and prostate cancer: a population-based case-control study in China. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[8]  B. Högstedt,et al.  Hyperinsulinaemia as a Risk Factor for Developing Benign Prostatic Hyperplasia , 2001, European Urology.

[9]  H. Guess.  Benign prostatic hyperplasia and prostate cancer. , 2001, Epidemiologic reviews.

[10]  M. Engelgau,et al.  Diabetes trends in the U.S.: 1990-1998. , 2000, Diabetes care.

[11]  H. Schumacher,et al.  Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. , 2000, The Journal of urology.

[12]  R. Roberts,et al.  Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status. , 1999, The Journal of urology.

[13]  S. Haffner,et al.  Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. , 1999, Archives of internal medicine.

[14]  B. Högstedt,et al.  Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. , 1999, Blood pressure.

[15]  D. Mellström,et al.  Components of the metabolic syndrome—risk factors for the development of benign prostatic hyperplasia , 1998, Prostate Cancer and Prostatic Diseases.

[16]  C. Leibson,et al.  Temporal Trends in Diabetes Incidence and Prevalence , 1997, Diabetes Care.

[17]  C. Leibson,et al.  TEMPORAL TRENDS IN DIABETES INCIDENCE AND PREVALENCE. AUTHORS' REPLY , 1997 .

[18]  P. Carretero,et al.  Urodynamic evaluation in simultaneous insulin-dependent diabetes mellitus and end stage renal disease. , 1996, The Journal of urology.

[19]  C G Chute,et al.  Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing. , 1995, JAMA.

[20]  J. Oesterling,et al.  Natural history of prostatism: factors associated with discordance between frequency and bother of urinary symptoms. , 1993, Urology.

[21]  H. Feldman,et al.  Families of lines: random effects in linear regression analysis. , 1988, Journal of applied physiology.

[22]  C. Hirsch.  Families of lines , 1983 .